STIMUVAM Trademark

Trademark Overview

On Tuesday, August 7, 2012, a trademark application was filed for STIMUVAM with the United States Patent and Trademark Office. The USPTO has given the STIMUVAM trademark a serial number of 79118531. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, August 7, 2022. This trademark is owned by Merck KGaA. The STIMUVAM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use in the field of oncology
stimuvam

General Information

Serial Number79118531
Word MarkSTIMUVAM
Filing DateTuesday, August 7, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, August 7, 2022
Registration Number4330032
Registration DateTuesday, May 7, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use in the field of oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address64293 Darmstadt
DE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address64293 Darmstadt
DE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address64293 Darmstadt
DE

Trademark Events

Event DateEvent Description
Saturday, March 4, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, March 4, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, October 10, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, September 17, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 17, 2020INVALIDATION PROCESSED
Thursday, August 13, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 13, 2019CANCELLED SECTION 71
Monday, May 7, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 6, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 19, 2013FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 19, 2013FINAL DISPOSITION PROCESSED
Wednesday, August 7, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 7, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, February 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 11, 2013ASSIGNED TO LIE
Tuesday, January 1, 2013REFUSAL PROCESSED BY IB
Friday, December 21, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 19, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 19, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 7, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 7, 2012REFUSAL PROCESSED BY MPU
Thursday, December 6, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 5, 2012NON-FINAL ACTION WRITTEN
Tuesday, November 27, 2012ASSIGNED TO EXAMINER
Tuesday, October 30, 2012APPLICATION FILING RECEIPT MAILED
Wednesday, October 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 22, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

stimuvam oncology field human preparations pharmaceutical